Nippon Shinyaku Co. Ltd. is a Japan company, located in Kobe-shi Hyogo. more detail is as below. Company Information Company Name: Nippon Shinyaku Co. Ltd.Country: JapanAddress: Kobe-shi HyogoInternational Area Code: 81Phone: 81 78-230-7654Fax: 81 78-222-9126Contact: Shigenobu MaekawaWebsite: www.nippon-shinyaku.co.jpProduct List: Sales Of Medical Pharmaceuticals Account For 83%.Category Activities: Sales Of Medical Pharmaceuticals Account For 83%.Type: ManufacturersProfile: Nippon Shinyaku Positions Itself As A Mid-sized Company In The Japanese Pharmaceutical Industry. I Would Like To Develop Our Business With Our Specialty As A Mid-sized Company, Drawing A Clear Line Against The Business Policy Of Megapharmas. In Order To Meet The Needs Of Suffering Patients And Medical Staff, We Try Our Best To Create Unique New Pharmaceutical Candidates, Develop Them Efficiently, Definitely Gain The Marketing Approval, And Launch The Products Quickly. Nippon Shinyaku, Basically, Takes A Stance Of Creating And Developing Drugs For Rare Diseases With Strong Social Demand. We Have Been Developing Drugs For The Diseases Such As Hematologic Malignancies And Pulmonary Hypertension, Which Are Not Yet Treated With Specific Remedy, Or Alcohol Dependence, Which Might Be A Cause Of Social Problems. After The Completion Of Human Genome Decoding In The 21st Century, Genomics And Proteomics Are Beginning To Be Applied To The New Drug Development. In These Circumstances, Nippon Shinyaku Promotes The World's Most Advanced Research And Development In The Area Of Rna Nucleic Acid Medicine, Which Is Expected As One Of The Most Progressive Future Medical Areas. Nippon Shinyaku Aims To Be A “bright, Energetic, Forward-looking” Company Whose Existence Is Reliably Recognized By The Society, By Applying Full Capability Of All Members Of The Staff, Under The Slogan Of “challenge, Speed, And Investigation”.Area: Hyogo More Links Move Inc. Nestle Japan Ltd. Nippon Shinyaku Co. Ltd. Taiyo Koko Co. Ltd. Nihon Light Inc. ‹ previous | next › Log in to post comments